Question

Which of the following statements is incorrect w.r.t Prasugrel?

• A. Not a prodrug
• B. P2Y purinergic receptor blocker
• C. Has a strong antiplatelet activity
• D. Causes intracranial hemorrhage in TIA patients.

Answer 1

The Correct Option is A

To identify the incorrect statement regarding Prasugrel, let's examine the options:

• Prasugrel is a prodrug: Prasugrel is indeed a prodrug. It is metabolized in the body to produce its active form, which then inhibits platelet aggregation. Hence, the statement "Not a prodrug" is incorrect.
• P2Y purinergic receptor blocker: Prasugrel functions by irreversibly inhibiting the P2Y₁₂ receptor on platelets, which is a type of purinergic receptor. Therefore, this statement is correct.
• Has a strong antiplatelet activity: Prasugrel is known for its potent antiplatelet activity, making this statement correct.
• Causes intracranial hemorrhage in TIA patients: Prasugrel can increase the risk of bleeding, including intracranial hemorrhage, particularly in patients with a history of transient ischemic attacks (TIAs). This makes the statement correct or at least contextually accurate.

Consequently, the statement "Not a prodrug" is the only one that is incorrect.